Here are the DEF 14A proxy statements from SANUWAVE Health, Inc. (SNWV) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow SNWV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SNWV filings page.
SANUWAVE Health, Inc. has called a virtual annual stockholder meeting for June 11, 2026, asking investors to vote on board elections, auditor ratification, and executive pay. Stockholders will elect five directors, including CEO and chairman Morgan Frank, to serve until the 2027 meeting.
Investors are also asked to ratify Baker Tilly US, LLP as independent auditor for 2026 and to approve, on a non-binding basis, compensation for named executive officers. The board highlights that four of five directors are independent and that it uses a lead independent director and fully independent audit, compensation, and nominating committees.
The proxy describes a Nasdaq-compliant clawback policy adopted in March 2025 and explains that, although prior periods were restated, no incentive-based compensation was received in the affected years, so no recovery was required. It also outlines equity incentive plans, option grants, related-party financings previously converted into equity, and current ownership levels of major shareholders and insiders.